| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000033540 |
| Receipt No. | R000038247 |
| Scientific Title | An exploratory randomized controlled trial testing efficacy of adjunctive electrical muscle stimulation used in early rehabilitation in patients with sepsis |
| Date of disclosure of the study information | 2018/07/27 |
| Last modified on | 2019/11/27 (Ver. 4) |
| Basic information | ||
| Public title | An exploratory randomized controlled trial testing efficacy of adjunctive electrical muscle stimulation used in early rehabilitation in patients with sepsis | |
| Acronym | Sepsis EMS study | |
| Scientific Title | An exploratory randomized controlled trial testing efficacy of adjunctive electrical muscle stimulation used in early rehabilitation in patients with sepsis | |
| Scientific Title:Acronym | Sepsis EMS study | |
| Region |
|
|
| Condition | |||
| Condition | Sepsis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This study investigates whether conventional physiotherapy plus EMS prevents muscle strength impairment more than physiotherapy alone. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary outcome is decrement in quadriceps strength (N/kg) on Day 15 versus Day 1. |
| Key secondary outcomes | Secondary outcomes are decrements in muscle strength grade determined by the manual muscle test (MMT) and in thickness of the rectus femoris muscle on Day 1, Day 8, and Day 15. The pre-hospitalization FIM score will be recorded on the day of hospital admission, and change in the FIM score on Day 15 compared with the prehospitalization value will be assessed |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The intervention group will receive EMS as follows. Belt electrodes of the Auto Tens Pro (Homer Ion Co. Ltd., Tokyo, Japan) will be placed around the abdomen, distal part of both thighs, and both ankles so that the entire lower limbs can be electrically stimulated. Once-daily 20-min stimulation (5-s stimulations at 20 Hz at 2-s intervals) will be delivered 5 days a week for 2 weeks. The electrical current value will be in the range of 2 to 15 mA. A total of 3 days will be used to determine the maximum electrical current value with an acceptable level of discomfort for each patient. A rehabilitation physician, one of the co-investigators, will supervise the 14-day intervention. On the same days as EMS, patients will receive conventional physiotherapy, as the control group will receive. | |
| Interventions/Control_2 | The control group will be treated solely using conventional physiotherapy over 14 days. Conventional physiotherapy comprises motor exercises and range of motion exercises. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.A signed informed consent form for participation in the study provided by the patient, or if difficult, by an authorized representative who has the legal capacity to decide the therapy strategy.
2.=> 20 years old 3.Diagnosis of sepsis |
|||
| Key exclusion criteria | 1.Presence of a pacemaker
2.Known primary systemic neuromuscular disease or intracranial disease at admission 3.Pre-hospitalization functional independence measure (FIM) score < 80, with inability to walk independently 4.Fracture or skin lesion (except contusion) in the region subjected to EMS (thigh, knee joint, ankle joint) 5.Pregnancy 6.Assessed as approaching or imminent death 7.Trauma 8.Unable to reach consensus 9.Determined by the physician-in-charge |
|||
| Target sample size | 70 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Center Hospital of the National Center for Global Health and Medicine | ||||||
| Division name | Department of Emergency Medicine and Critical Care | ||||||
| Zip code | |||||||
| Address | 1-21-1, Toyama, Shinjuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3202-7181 | ||||||
| akimura@hosp.ncgm.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Center Hospital of the National Center for Global Health and Medicine | ||||||
| Division name | Department of Emergency Medicine and Critical Care | ||||||
| Zip code | |||||||
| Address | 1-21-1, Toyama, Shinjuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3202-7181 | ||||||
| Homepage URL | |||||||
| ktakii@hosp.ncgm.go.jp | |||||||
| Sponsor | |
| Institute | Center Hospital of the National Center for Global Health and Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Center Hospital of the National Center for Global Health and Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038247 |